日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway.

通过阻断IL-33/IL1RL1通路，双重靶向肿瘤细胞和免疫微环境

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-61567-7
Fu Denggang, Jiang Hua, Long Alan, Harris Ella, Guo Hongfen, Capitano Maegan L, Wrangle John, Faust Joshua R, Gopalakrishnapillai Anilkumar, Pasupuleti Santhosh Kumar, Ramdas Baskar, Kapur Reuben, Barwe Sonali P, Cheung Nai-Kong V, Paczesny Sophie
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Comparison of targeting two antigens (GPA33 versus HER2) for (225)Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer

比较靶向两种抗原（GPA33 与 HER2）的（225）Ac 预靶向 α 放射免疫疗法治疗结直肠癌

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.116062
Rinne, Sara S; Vargas, Daniela Burnes; Vaughn, Brett A; Katugampola, Sumudu; Miller, Brian W; Veach, Darren R; Punzalan, Blesida; de Stanchina, Elisa; Yaeger, Rona; Miranda, Ileana C; Xu, Hong; Guo, Hongfen; Schwartz, Jazmin; Fung, Edward K; Howell, Roger W; Larson, Steven M; Cheung, Nai-Kong V; Cheal, Sarah M
肿瘤
肠癌
肿瘤免疫
HER2
免疫/内分泌
发表日期：2025
文献求助 收藏

IntraOmmaya compartmental radioimmunotherapy using (131)I-omburtamab-pharmacokinetic modeling to optimize therapeutic index

利用 (131)I-omburtamab 进行 Ommaya 区室放射免疫治疗，通过药代动力学模型优化治疗指数

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-020-05050-z
Yerrabelli, Rahul S; He, Ping; Fung, Edward K; Kramer, Kim; Zanzonico, Pat B; Humm, John L; Guo, Hongfen; Pandit-Taskar, Neeta; Larson, Steven M; Cheung, Nai-Kong V
免疫/内分泌
发表日期：2021
文献求助 收藏

A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy

一种新型多聚体IL15/IL15Rα-Fc复合物可增强癌症免疫治疗

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2021.1893500
Xu, Hong; Buhtoiarov, Ilia N; Guo, Hongfen; Cheung, Nai-Kong V
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2021
文献求助 收藏